160 related articles for article (PubMed ID: 15032178)
1. T-1249 development hits a snag.
AIDS Clin Care; 2004 Feb; 16(2):15. PubMed ID: 15032178
[No Abstract] [Full Text] [Related]
2. On approval.
Huff B
GMHC Treat Issues; 2001 Oct; 15(10):5-8. PubMed ID: 11727570
[No Abstract] [Full Text] [Related]
3. New fixed dose once-a-day combinations. Interview by John S. James.
Cohen C
IAPAC Mon; 2004 Nov; 10(11):414-5, 432. PubMed ID: 15744891
[No Abstract] [Full Text] [Related]
4. An overview of the drug approval process.
Martinez LJ
Res Initiat Treat Action; 2002; 8(1):11-7. PubMed ID: 12489521
[No Abstract] [Full Text] [Related]
5. A look ahead at this year's drug approvals.
Proj Inf Perspect; 2007 Apr; (43):4-7. PubMed ID: 17684824
[No Abstract] [Full Text] [Related]
6. FDA notifications. FDA approves raltegravir for HIV-1 treatment-naive patients.
AIDS Alert; 2009 Sep; 24(9):106-7. PubMed ID: 19938313
[No Abstract] [Full Text] [Related]
7. FDA notifications. FDA postpones CCR5 Antagonist Review Group meeting.
AIDS Alert; 2006 Jan; 21(1):11-2. PubMed ID: 16470945
[No Abstract] [Full Text] [Related]
8. 100th HIV/AIDS antiretroviral drug approved by PEPFAR.
AIDS Patient Care STDS; 2009 Nov; 23(11):988-9. PubMed ID: 19938372
[No Abstract] [Full Text] [Related]
9. Experimental drug quickly suppresses HIV.
AIDS Read; 2005 Apr; 15(4):150. PubMed ID: 15844233
[No Abstract] [Full Text] [Related]
10. FDA grants tentative approval to first generic version of antiretroviral Viread.
AIDS Patient Care STDS; 2008 Jan; 22(1):86. PubMed ID: 18453039
[No Abstract] [Full Text] [Related]
11. Emerging drugs in the fight against HIV disease.
Rosenthal E
HRSA Careaction; 2003 Feb; ():1-8. PubMed ID: 12739497
[No Abstract] [Full Text] [Related]
12. FDA gives salvage therapy testing a push forward.
Bass E
AIDS Treat News; 2001 Mar; (362):3-7, 1. PubMed ID: 11569956
[TBL] [Abstract][Full Text] [Related]
13. Update on new antiretroviral drugs. An interview with Harold Kessler, M.D. by Matt Sharp.
Kessler H
Posit Aware; 2007; 18(6):22-4. PubMed ID: 18074429
[No Abstract] [Full Text] [Related]
14. FDA notifications. Pediatric HIV infection guidelines for use of ARTs are revised.
AIDS Alert; 2008 Apr; 23(4):46-7. PubMed ID: 19255980
[No Abstract] [Full Text] [Related]
15. Generic stavudine approved.
AIDS Patient Care STDS; 2009 May; 23(5):396-7. PubMed ID: 19422067
[No Abstract] [Full Text] [Related]
16. T-20 (Fuzeon) gets priority review.
AIDS Treat News; 2002 Oct; (384):4-5. PubMed ID: 12434762
[No Abstract] [Full Text] [Related]
17. FDA notifications. Tentative approval granted for combo antiretroviral drug.
AIDS Alert; 2007 Oct; 22(10):117-8. PubMed ID: 18416009
[No Abstract] [Full Text] [Related]
18. FDA notifications. Changes to ART guidelines detailed by the FDA.
AIDS Alert; 2008 Mar; 23(3):33-4. PubMed ID: 18663777
[No Abstract] [Full Text] [Related]
19. AIDS treatment. Drugmakers test restrictions on generics in U.S. programs.
Cohen J
Science; 2004 Oct; 306(5694):213. PubMed ID: 15472049
[No Abstract] [Full Text] [Related]
20. Long path to approval. A look back at the road to Fuzeon.
GMHC Treat Issues; 2003 Mar; 17(3):1-5. PubMed ID: 12728856
[No Abstract] [Full Text] [Related]
[Next] [New Search]
